Bessemer Group Inc Alnylam Pharmaceuticals, Inc. Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 33 shares of ALNY stock, worth $8,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$8,210

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$233.81 - $287.01 $7,715 - $9,471	33 New	33 $9,000
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $17,930 - $22,223	105 Added 28.3%	476 $84,000
Q2 2023 Aug 10, 2023	BUY	$185.01 - $212.05 $68,638 - $78,670	371 New	371 $70,000
Q3 2022 Nov 09, 2022	BUY	$138.54 - $232.0 $11.7 Million - $19.5 Million	84,256 Added 351066.66%	84,280 $16.9 Million
Q2 2022 Aug 10, 2022	BUY	$120.42 - $169.29 $2,890 - $4,062	24 New	24 $4,000
Q4 2021 Jan 27, 2022	SELL	$159.56 - $209.29 $6,222 - $8,162	-39 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $6,620 - $8,101	39 New	39 $7,000
Q2 2021 Aug 06, 2021	SELL	$128.63 - $176.89 $99,173 - $136,382	-771 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$126.83 - $175.69 $7,990 - $11,068	63 Added 8.9%	771 $108,000
Q4 2020 Feb 09, 2021	SELL	$122.97 - $147.0 $36,891 - $44,100	-300 Reduced 29.76%	708 $92,000
Q3 2020 Nov 12, 2020	SELL	$121.19 - $165.49 $24,238 - $33,098	-200 Reduced 16.56%	1,008 $147,000
Q2 2020 Aug 05, 2020	BUY	$104.21 - $156.44 $125,885 - $188,979	1,208 New	1,208 $179,000
Q2 2019 Jul 19, 2019	SELL	$65.86 - $92.79 $3,293 - $4,639	-50 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$72.76 - $93.45 $2,401 - $3,083	-33 Reduced 39.76%	50 $5,000
Q4 2018 Feb 12, 2019	BUY	$62.67 - $88.33 $5,201 - $7,331	83 New	83 $6,000
Q4 2017 Jan 30, 2018	SELL	$114.49 - $139.98 $20,035 - $24,496	-175 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$72.53 - $118.27 $12,692 - $20,697	175	175 $21,000

Others Institutions Holding ALNY

# of Institutions

642

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.11 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.14 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.38 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.3 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.23 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account